Hoth Therapeutics, Inc. Quarterly Costs and Expenses in USD from Q2 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Hoth Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2022 to Q4 2023.
  • Hoth Therapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2023 was -$61K.
  • Hoth Therapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2023 was $29K.
  • Hoth Therapeutics, Inc. annual Costs and Expenses for 2023 was $29K, a 45.3% decline from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $29K -$61K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $30K +$18K +150% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $30K +$15K +100% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $30K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q3 2022 $12K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $15K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.